Riskpilot← Back to searchSign inGet full accessCOLOSSEUMKLINIKKEN DANMARK ApS
APSActiveCVR 10097266Herlev Bygade 14, 1.Activities of holding companies · NACE 6421Est. 200222 employees
Revenue 2024
DKK 12,7M
-37% vs 2023
EBITDA margin
-71.4%
-151% vs 2023
Equity ratio
-29.1%
Financial strength
Net profit 2024
DKK -15,3M
+70% vs 2023
| Revenue | DKK 12,7M | -37% |
| EBITDA | DKK -9,1M | -151% |
| Net profit | DKK -15,3M | +70% |
| Total assets | DKK 262,8M | +5% |
| Equity | DKK -76,5M | -25% |
| Employees | 22 | — |
Legal name
COLOSSEUMKLINIKKEN DANMARK ApS
CVR number
10097266
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
1. oktober 2002
Share capital
DKK 140.000
Employees
22 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to direktører, af to bestyrelsesmedlemmer, af et bestyrelsesmedlem og en direktør eller af den samlede bestyrelse
Company purpose
Selskabets formål er enten selv eller via kapitalbesiddelser i andre selskaber at drive tandlægevirksomhed i Danmark, herunder fungere som administrationsselskab.
Address
Herlev Bygade 14, 1.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -873 | -44 | -86 | -122 | -196 | -1.663 | -3.532 | 2.079 | 5.351 | 13.239 | 15.125 | 20.067 | 12.707 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -636 | -2.317 | -7.113 | -10.269 | -11.980 | -13.570 | -12.099 |
| EBITDA | -873 | -500 | -471 | -122 | -196 | -1.663 | -4.168 | -2.918 | -6.494 | -3.698 | -4.619 | -3.616 | -9.069 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -1.314 | -3.029 | -8.514 | -13.805 | -18.814 | -16.803 | -20.929 |
| EBIT | -873 | -500 | -471 | -122 | -196 | -1.663 | -5.482 | -5.947 | -15.008 | -17.503 | -23.433 | -20.420 | -29.998 |
| Net financials | -873 | 28 | -2.075 | 1.602 | -934 | 390 | -2.202 | -4.074 | -2.562 | -4.389 | -2.066 | -29.000 | 14.490 |
| Profit before tax | -1.746 | -472 | -2.546 | 1.480 | -1.131 | -1.273 | -7.985 | -10.833 | -18.726 | -22.881 | -26.390 | -50.562 | -16.356 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -1.082 |
| Net profit | -1.746 | -472 | -2.546 | 1.480 | -1.131 | -1.273 | -7.985 | -10.833 | -18.726 | -22.881 | -26.390 | -50.562 | -15.274 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 21.895 | 20.389 | 13.906 | 9.660 | 9.217 | 10.880 | 46.046 | 102.308 | 170.558 | 219.009 | 205.992 | 249.557 | 262.808 |
| Equity | -1.026 | -1.498 | -4.045 | -2.565 | -3.696 | -4.968 | -4.653 | -15.486 | 38.571 | 15.690 | -10.700 | -61.261 | -76.536 |
| Long-term debt | 19.540 | 17.001 | 14.501 | 7.981 | 7.981 | 10.231 | 43.089 | 106.408 | 96.153 | 133.899 | 170.326 | 251.272 | 264.883 |
| Short-term debt | 2.678 | 3.518 | 3.449 | 4.245 | 4.932 | 5.617 | 7.610 | 4.569 | 8.517 | 23.078 | 15.216 | 41.297 | 64.460 |
| Total debt | 22.218 | 20.519 | 17.950 | 12.225 | 12.912 | 15.848 | 50.699 | 110.977 | 104.670 | 156.977 | 185.541 | 292.569 | 329.343 |
EBITDA margin
-71.4%
This company
15.8%
Market median
-552% vs market
20122024
Equity ratio
-29.1%
This company
38.2%
Market median
-176% vs market
20122024
Return on equity
-1527422200.0%
This company
18.4%
Market median
-8301207709% vs market
20122024
Net profit margin
-120.2%
This company
8.1%
Market median
-1584% vs market
20122024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20122024
Debt / equity
4.43×
This company
0.62×
Market median
-615% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MB Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
GL Management | Management | 2011 | — | — |
PM Management | Management | 2018 | — | — |
MR Management | Management | 2022 | — | — |
RE Management | Management | 2015 | — | — |
| Founder | 2002 | — | — | |
LD Chief Executive Officer | Chief Executive Officer | 2015 | — | — |
SH Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
JM Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
CS Management | Management | 2025 | — | — |
PR Management | Management | 2012 | — | — |
AL Management | Management | 2011 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2003 | — | — | |
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2011 | — | — | |
| Board of Directors | 2006 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2020 | |
| Individual | 100.0% | 100.0% | 2007 | |
| Individual | 100.0% | 100.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
COLOSSEUMKLINIKKEN DANMARK ApS (this company)
Tandlægeselskabet Colosseum Roskilde ApSBoard members of COLOSSEUMKLINIKKEN DANMARK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malin Birgitta Schmidt | Chief Executive Officer | 0 companies |
| Gard Lauvsnes | Management | 0 companies |
| Pål Mørkved | Management | 0 companies |
| Mathias Riis Damgaard | Management | 0 companies |
| Ragnhild Elisabeth Hauge Waters | Management | 0 companies |
| COLOSSEUM DENTAL AS Org.nr. 981 400 348 | Founder | 0 companies |
| Lars David Halldén | Chief Executive Officer | 0 companies |
| Synne Hermansen Røine | Chief Executive Officer | 0 companies |
| Jens Mondrup | Chief Executive Officer | 0 companies |
| Christopher Sebastian Östberg | Management | 0 companies |
| Per Rehnberg | Management | 0 companies |
| Anders Lennart Nylander | Management | 0 companies |
| Raoul Francis Dias | Board of Directors | 0 companies |
| John Halstensen | Board of Directors | 0 companies |
| Tor Johan Finne | Board of Directors | 0 companies |
| Philippe Olivier Fuchs | Board of Directors | 0 companies |
| Daniel Fehr | Board of Directors | 0 companies |
| Dean Zuzic | Chairman | 0 companies |
| Ole Mjåtvedt | Board of Directors | 0 companies |